A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208)
Clinical trial NCT01362530 · COMPLETED
Trial details
- NCT number
- NCT01362530
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-13
- Primary completion
- 2013-03-14
- Enrollment
- 307
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.